scispace - formally typeset
Open AccessJournal ArticleDOI

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.

TLDR
It is proposed that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19.
About
This article is published in Cell.The article was published on 2020-05-28 and is currently open access. It has received 3286 citations till now.

read more

Citations
More filters
Journal ArticleDOI

SARS-CoV-2 (COVID-19) and cystic fibrosis.

TL;DR: A variety of factors may mitigate the severity of SARS-CoV-2 in CF, including the fact that many CF patients are treated with azithromycin and the CF lung contains high levels of serine protease inhibitors including ecotin and SERPINB1, which are predicted to reduce the ability of TMPRSS2 to facilitate Sars-Cov-2 entry into airway epithelial cells.
Posted ContentDOI

A single-cell and spatial atlas of autopsy tissues reveals pathology and cellular targets of SARS-CoV-2

Toni Delorey, +125 more
- 25 Feb 2021 - 
TL;DR: In this paper, the authors used single-cell and single-nucleus RNA-Seq of lung, kidney, liver, and heart tissues collected during the clinical autopsy of 17 individuals who succumbed to the SARS-CoV-2 pandemic.
Journal ArticleDOI

Evidence of a wide gap between COVID-19 in humans and animal models: a systematic review.

TL;DR: Most of the animal models of CO VID-19 recapitulated mild pattern of human COVID-19 with full recovery phenotype, suggesting a wide gap between COVID -19 in humans and animal models.
Journal ArticleDOI

PPARγ Cistrome Repression during Activation of Lung Monocyte-Macrophages in Severe COVID-19

TL;DR: Results demonstrate for the first time, the involvement of the PPARγ complex in severe COVID-19 lung disease and suggest strongly its role in the major monocyte / macrophage-mediated inflammatory storm.
Journal ArticleDOI

Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics.

TL;DR: The article ends with the development of different immunomodulatory and immunotherapeutics strategies, including vaccines waiting for their approval in humans as prophylaxis or treatment measures.
References
More filters
Journal ArticleDOI

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

TL;DR: This work presents DESeq2, a method for differential analysis of count data, using shrinkage estimation for dispersions and fold changes to improve stability and interpretability of estimates, which enables a more quantitative analysis focused on the strength rather than the mere presence of differential expression.
Journal ArticleDOI

Fast gapped-read alignment with Bowtie 2

TL;DR: Bowtie 2 combines the strengths of the full-text minute index with the flexibility and speed of hardware-accelerated dynamic programming algorithms to achieve a combination of high speed, sensitivity and accuracy.
Book

ggplot2: Elegant Graphics for Data Analysis

TL;DR: This book describes ggplot2, a new data visualization package for R that uses the insights from Leland Wilkisons Grammar of Graphics to create a powerful and flexible system for creating data graphics.
Journal ArticleDOI

A Novel Coronavirus from Patients with Pneumonia in China, 2019.

TL;DR: Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily, which is the seventh member of the family of coronaviruses that infect humans.
Journal ArticleDOI

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

TL;DR: Characteristics of patients who died were in line with the MuLBSTA score, an early warning model for predicting mortality in viral pneumonia, and further investigation is needed to explore the applicability of the Mu LBSTA scores in predicting the risk of mortality in 2019-nCoV infection.
Related Papers (5)